| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name |  DisGeNet score | DisGeNet_sourceDB |
| 25 | ABL1 | C0023473 | Myeloid Leukemia, Chronic | 0.531599452889936 | BEFREE;CTD_human;GAD;LHGDN;ORPHANET |
| 25 | ABL1 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.241397612152275 | BEFREE;CTD_human;LHGDN |
| 25 | ABL1 | C0027022 | Myeloproliferative disease | 0.235165028379277 | BEFREE;HPO |
| 25 | ABL1 | C1458155 | Mammary Neoplasms | 0.203007639249027 | BEFREE;CTD_human;LHGDN |
| 25 | ABL1 | C0596263 | Carcinogenesis | 0.202197814273705 | BEFREE;CTD_human |
| 25 | ABL1 | C0836924 | Thrombocytosis | 0.201923087489492 | BEFREE;HPO |
| 25 | ABL1 | C0014859 | Esophageal Neoplasms | 0.200274726784213 | BEFREE;CTD_human |
| 25 | ABL1 | C0032927 | Precancerous Conditions | 0.200274726784213 | BEFREE;CTD_human |
| 25 | ABL1 | C0001418 | Adenocarcinoma | 0.2 | CTD_human |
| 25 | ABL1 | C0015672 | Fatigue | 0.2 | HPO |
| 25 | ABL1 | C0015967 | Fever | 0.2 | HPO |
| 25 | ABL1 | C0023518 | Leukocytosis | 0.2 | HPO |
| 25 | ABL1 | C0023903 | Liver neoplasms | 0.2 | CTD_human |
| 25 | ABL1 | C0027659 | Neoplasms, Experimental | 0.2 | CTD_human |
| 25 | ABL1 | C0038002 | Splenomegaly | 0.2 | HPO |
| 25 | ABL1 | C0040034 | Thrombocytopenia | 0.2 | HPO |
| 25 | ABL1 | C0232462 | Decrease in appetite | 0.2 | HPO |
| 25 | ABL1 | C0392386 | Decreased platelet count | 0.2 | HPO |
| 25 | ABL1 | C0857460 | Increased number of platelets | 0.2 | HPO |
| 25 | ABL1 | C4025736 | Abnormality of basophils | 0.2 | HPO |
| 25 | ABL1 | C0023418 | leukemia | 0.0833940083568835 | BEFREE;GAD;LHGDN |
| 25 | ABL1 | C0030567 | Parkinson Disease | 0.0802747267842131 | BEFREE;RGD |
| 25 | ABL1 | C0041956 | Ureteral obstruction | 0.08 | RGD |
| 25 | ABL1 | C0023449 | Acute lymphocytic leukemia | 0.0519233622162759 | BEFREE |
| 25 | ABL1 | C0005699 | Blast Phase | 0.0293670551561672 | BEFREE;LHGDN |
| 25 | ABL1 | C1292778 | Chronic myeloproliferative disorder | 0.021978142737048 | BEFREE |
| 25 | ABL1 | C1960397 | Philadelphia chromosome-positive acute lymphoblastic leukemia | 0.0181319677580646 | BEFREE |
| 25 | ABL1 | C0023467 | Leukemia, Myelocytic, Acute | 0.0164692516754688 | BEFREE;LHGDN |
| 25 | ABL1 | C0242596 | Neoplasm, Residual | 0.0140110659948681 | BEFREE |
| 25 | ABL1 | C0023470 | Myeloid Leukemia | 0.0124776962499083 | BEFREE;GAD;LHGDN |
| 25 | ABL1 | C0598766 | Leukemogenesis | 0.0112637981527371 | BEFREE |
| 25 | ABL1 | C0023474 | Leukemia, Myeloid, Chronic-Phase | 0.010989071368524 | BEFREE |
| 25 | ABL1 | C1292769 | Precursor B-cell lymphoblastic leukemia | 0.0101648910158847 | BEFREE |
| 25 | ABL1 | C3714514 | Infection | 0.00819873739444126 | LHGDN |
| 25 | ABL1 | C0032463 | Polycythemia Vera | 0.00740326779643645 | BEFREE;LHGDN |
| 25 | ABL1 | C0006142 | Malignant neoplasm of breast | 0.0072865981044939 | BEFREE;GAD |
| 25 | ABL1 | C0085669 | Acute leukemia | 0.0071428963895406 | BEFREE |
| 25 | ABL1 | C0040028 | Thrombocythemia, Essential | 0.00685381422801025 | BEFREE;LHGDN |
| 25 | ABL1 | C0751606 | Adult Acute Lymphocytic Leukemia | 0.0057692624684751 | BEFREE |
| 25 | ABL1 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0057692624684751 | BEFREE |
| 25 | ABL1 | C0024121 | Lung Neoplasms | 0.0057405517138406 | BEFREE;LHGDN |
| 25 | ABL1 | C0001815 | Primary Myelofibrosis | 0.005494535684262 | BEFREE |
| 25 | ABL1 | C0002395 | Alzheimer's Disease | 0.00513994098810175 | GAD;LHGDN |
| 25 | ABL1 | C0008626 | Congenital chromosomal disease | 0.0049450821158358 | BEFREE |
| 25 | ABL1 | C0279543 | Philadelphia chromosome positive chronic myelogenous leukemia | 0.0046703553316227 | BEFREE |
| 25 | ABL1 | C0000744 | Abetalipoproteinemia | 0.0043956285474096 | BEFREE |
| 25 | ABL1 | C0023452 | Leukemia, Lymphocytic, Acute, L1 | 0.0043956285474096 | BEFREE |
| 25 | ABL1 | C0677936 | Refractory cancer | 0.0043956285474096 | BEFREE |
| 25 | ABL1 | C0023448 | Lymphoid leukemia | 0.0035714481947703 | BEFREE |
| 25 | ABL1 | C0332996 | Persistent embryonic structure | 0.0035714481947703 | BEFREE |
| 25 | ABL1 | C0376545 | Hematologic Neoplasms | 0.0030219946263441 | BEFREE |
| 25 | ABL1 | C0004623 | Bacterial Infections | 0.00300763924902685 | BEFREE;LHGDN |
| 25 | ABL1 | C0014457 | Eosinophilia | 0.00300763924902685 | BEFREE;LHGDN |
| 25 | ABL1 | C1140680 | Malignant neoplasm of ovary | 0.0029564820917142 | BEFREE;GAD |
| 25 | ABL1 | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
| 25 | ABL1 | C0026827 | Muscle hypotonia | 0.00273291246481375 | LHGDN |
| 25 | ABL1 | C0032461 | Polycythemia | 0.00273291246481375 | LHGDN |
| 25 | ABL1 | C0026987 | Myelofibrosis | 0.0024725410579179 | BEFREE |
| 25 | ABL1 | C0678222 | Breast Carcinoma | 0.0024725410579179 | BEFREE |
| 25 | ABL1 | C0001973 | Alcoholic Intoxication, Chronic | 0.002407028523288 | GAD |
| 25 | ABL1 | C0019693 | HIV Infections | 0.002407028523288 | GAD |
| 25 | ABL1 | C0023485 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.0021978142737048 | BEFREE |
| 25 | ABL1 | C1709527 | B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 | 0.0021978142737048 | BEFREE |
| 25 | ABL1 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0021978142737048 | BEFREE |
| 25 | ABL1 | C0027708 | Nephroblastoma | 0.0019230874894917 | BEFREE |
| 25 | ABL1 | C0376544 | Hematopoietic Neoplasms | 0.0019230874894917 | BEFREE |
| 25 | ABL1 | C0238198 | Gastrointestinal Stromal Tumors | 0.0016483607052786 | BEFREE |
| 25 | ABL1 | C0280100 | solid tumor | 0.0016483607052786 | BEFREE |
| 25 | ABL1 | C0021051 | Immunologic Deficiency Syndromes | 0.0013736339210655 | BEFREE |
| 25 | ABL1 | C0023434 | Chronic Lymphocytic Leukemia | 0.0013736339210655 | BEFREE |
| 25 | ABL1 | C0085281 | Addictive Behavior | 0.0013736339210655 | BEFREE |
| 25 | ABL1 | C0349636 | Pre B-cell acute lymphoblastic leukemia | 0.0013736339210655 | BEFREE |
| 25 | ABL1 | C0007789 | Cerebral Palsy | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0018939 | Hematological Disease | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0023440 | Acute Erythroblastic Leukemia | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0023480 | Leukemia, Myelomonocytic, Chronic | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0023481 | Chronic Neutrophilic Leukemia | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0024299 | Lymphoma | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0026499 | Monosomy | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0026764 | Multiple Myeloma | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0029925 | Ovarian Carcinoma | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0376358 | Malignant neoplasm of prostate | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0521530 | Lung consolidation | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C1292772 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C1837218 | Cleft palate, isolated | 0.0010989071368524 | BEFREE |
| 25 | ABL1 | C0006413 | Burkitt Lymphoma | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0023464 | Acute biphenotypic leukemia | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0178874 | Tumor Progression | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0206141 | Idiopathic Hypereosinophilic Syndrome | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0279549 | Philadelphia chromosome negative chronic myelogenous leukemia | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0600139 | Prostate carcinoma | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0677932 | Progressive Neoplastic Disease | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C2004493 | Leukemia, B-Cell | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C2939461 | Myeloid neoplasm | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C3539781 | Progressive cGVHD | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C4054188 | Ph-Like Acute Lymphoblastic Leukemia | 0.0008241803526393 | BEFREE |
| 25 | ABL1 | C0002871 | Anemia | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0009402 | Colorectal Carcinoma | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0013080 | Down Syndrome | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0017638 | Glioma | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0023472 | Leukemia, Myeloid, Accelerated Phase | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0024314 | Lymphoproliferative Disorders | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0027627 | Neoplasm Metastasis | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0085702 | Monocytosis | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0238463 | Papillary thyroid carcinoma | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0392514 | Hereditary hemochromatosis | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0424295 | Hyperactive behavior | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0432412 | Chromosome 8, trisomy | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0677886 | Epithelial ovarian cancer | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0856053 | leukaemia secondary | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C1282609 | Granulocytosis | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C1292771 | Chronic myelogenous leukemia, BCR/ABL positive | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C1301355 | Myelodysplastic-Myeloproliferative Diseases | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C1370868 | refractory CML | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C1527249 | Colorectal Cancer | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C1863727 | HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2 | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C2861580 | Chronic myeloid leukemia, BCR/ABL-positive | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C3539878 | Triple Negative Breast Neoplasms | 0.0005494535684262 | BEFREE |
| 25 | ABL1 | C0002736 | Amyotrophic Lateral Sclerosis | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0007222 | Cardiovascular Diseases | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0011991 | Diarrhea | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0012546 | Diphtheria | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0015397 | Disorder of eye | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0015625 | Fanconi Anemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0017152 | Gastritis | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0017636 | Glioblastoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0018213 | Graves Disease | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0021400 | Influenza | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0022665 | Kidney Neoplasm | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0023462 | Acute Megakaryocytic Leukemias | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0023487 | Acute Promyelocytic Leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0023493 | Adult T-Cell Lymphoma/Leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0023524 | Leukoencephalopathy, Progressive Multifocal | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0024301 | Lymphoma, Follicular | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0027341 | Nail-Patella Syndrome | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0032131 | Plasmacytoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0035335 | Retinoblastoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0035369 | Retroviridae Infections | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0035920 | Rubella | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0036421 | Systemic Scleroderma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0036920 | Sezary Syndrome | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0040100 | Thymoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0042769 | Virus Diseases | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0043119 | Werner Syndrome | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0079731 | B-Cell Lymphomas | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0085077 | Sweet Syndrome | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0085110 | Severe Combined Immunodeficiency | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0152018 | Esophageal carcinoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0152276 | Granulocytic Sarcoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0153690 | Secondary malignant neoplasm of bone | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0206142 | Eosinophilic leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0242379 | Malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0242422 | Parkinsonian Disorders | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0278488 | Carcinoma breast stage IV | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0278519 | recurrent childhood acute lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0278787 | relapsing chronic myelogenous leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0279592 | T-cell adult acute lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0279593 | B-cell adult acute lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0279628 | Adenocarcinoma Of Esophagus | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0280141 | Acute Undifferentiated Leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0280251 | stage, chronic myelogenous leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0280449 | secondary acute myeloid leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0302592 | Cervix carcinoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0338451 | Frontotemporal dementia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0346421 | Chronic eosinophilic leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0349639 | Juvenile Myelomonocytic Leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0398639 | Amegakaryocytic thrombocytopenia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0406775 | Symmetrical dyschromatosis of extremities | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0410000 | Overlap syndrome | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0456889 | Enteropathy-Associated T-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0524851 | Neurodegenerative Disorders | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0546837 | Malignant neoplasm of esophagus | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0684249 | Carcinoma of lung | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0867389 | Chronic graft-versus-host disease | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C0920028 | Leukaemia recurrent | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1168401 | Squamous cell carcinoma of the head and neck | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1261473 | Sarcoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1279296 | Chronic leukemia (category) | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1292758 | Precursor T-cell lymphoblastic lymphoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1306460 | Primary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1306759 | Eosinophilic disorder | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1327920 | childhood chronic myelogenous leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1336745 | Thymic Lymphoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1621958 | Glioblastoma Multiforme | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1837249 | Malformations of Cortical Development, Group II | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1845247 | Indolence | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1850900 | Familial primary gastric lymphoma | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1857276 | Trichohepatoenteric Syndrome | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C1863340 | PITUITARY ADENOMA PREDISPOSITION (disorder) | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C2363142 | T-Cell Prolymphocytic Leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C2745900 | Promyelocytic leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C2826025 | Mixed phenotype acute leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C3853548 | Pdgfra-Associated Chronic Eosinophilic Leukemia | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C4022560 | Splanchnic vein thrombosis | 0.0002747267842131 | BEFREE |
| 25 | ABL1 | C4049328 | Kidney Medullary Carcinoma | 0.0002747267842131 | BEFREE |